On April 21, 2026, ECRI, a global healthcare quality and safety nonprofit organization, announced the spin-off of its healthcare spend management and recall management solutions into an independent company named Staritas. The move is backed by a growth investment from Accel-KKR, a global technology-focused investment firm. This strategic separation aims to enhance innovation and scalability in healthcare supply chain intelligence through AI-driven tools and real-time data analytics.
According to ECRI’s press release, the spin-off allows Staritas to build on five decades of expertise in spend and recall management while accelerating the development of advanced solutions for healthcare supply chain leaders. Marcus Schabacker, CEO, MD, and president of ECRI, emphasized that the independence of Staritas will enable greater investment in user experience, AI integration, and continuous innovation, all while maintaining the organization’s legacy of transparency and objectivity.
Accel-KKR’s involvement signals confidence in Staritas’s potential to transform how healthcare organizations manage supply chain risks. Park Durrett, managing director at Accel-KKR, noted that the firm is proud to support a company with a proven track record in independent datasets and domain expertise, and remains committed to upholding the principles that have defined ECRI’s work for decades.
Staritas will continue to offer its Automated Recall Management software, which uses advanced algorithms to match recalls with hospital inventory, enabling faster response times and reducing manual workload. The system provides early warnings—sometimes days or weeks before FDA notifications—helping healthcare providers act swiftly to protect patient safety and maintain compliance. In a referenced case study, Children’s Nebraska utilized the platform to identify and isolate defective Teleflex endotracheal tubes following a Staritas alert issued four weeks prior to the FDA recall, resolving the issue within one business day through cross-departmental coordination.
The Spend Management solution, also now under Staritas, leverages ECRI’s extensive, independently sourced purchasing data to help hospitals benchmark prices, navigate shortages, and craft resilient procurement decisions. By combining spend and recall intelligence, Staritas aims to shift healthcare supply chain management from reactive, event-driven responses to proactive, continuous strategies powered by real-time insights.
As an independent entity, Staritas plans to expand its use of artificial intelligence and machine learning to deliver predictive analytics and actionable intelligence to healthcare supply chain leaders globally. The company intends to deepen its focus on data-driven resilience, particularly in light of increasing supply chain complexity and regulatory demands.
The spin-off reflects a broader trend in healthcare technology, where specialized units are separated from parent organizations to attract targeted investment and accelerate innovation. For ECRI, this allows the parent organization to concentrate on its core mission of improving healthcare quality and safety through evidence-based guidance, while Staritas operates with the agility of a venture-backed tech firm.
Stakeholders in hospitals, health systems, and group purchasing organizations are expected to benefit from Staritas’s enhanced capabilities in risk mitigation, cost savings, and operational efficiency. The company’s commitment to independent, unbiased data remains a cornerstone of its value proposition, especially in an era where supply chain disruptions can directly impact patient care.
As of the announcement, no further details were disclosed regarding Staritas’s leadership team, headquarters location, or specific product roadmap beyond the stated focus on AI-powered solutions and global expansion. ECRI confirmed that it will maintain a relationship with Staritas as a former division but will not retain ownership or operational control.
For healthcare leaders seeking to stay informed about recalls, supply shortages, or purchasing benchmarks, Staritas offers access to its platforms through direct engagement. Official updates, product information, and contact details are available through the company’s website, which ECRI referenced in its announcement.
The development marks a significant step in the evolution of healthcare supply chain intelligence, combining decades of institutional knowledge with novel capital and technological ambition. As healthcare systems continue to face pressures from global disruptions, inflation, and regulatory scrutiny, tools like those offered by Staritas may play an increasingly vital role in ensuring both safety and sustainability.
Readers are encouraged to follow official channels for updates on Staritas’s progress and to share insights on how data-driven solutions are shaping the future of healthcare operations.